Alternatives to MNDL Bio

AI-driven digital twin of embryo development for cell-based therapies.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Developing advanced plant-based ingredients for more resilient and nutritious food systems.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Synthetic biology platform for environmental sustainability solutions.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.